Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 4627s-4629s, September 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erfle, V.
Right arrow Articles by Goebel, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erfle, V.
Right arrow Articles by Goebel, F. D.

Prevalence of Antibodies to HTLV-III in AIDS Risk Groups in West Germany1

Volker Erfle2, Rüdiger Hehlmann, Werner Mellert, Gerhard Krüger, Erhard Seifried, Hermann Heimpel, Heinrich Rasokat, Eckhardt Lechler, Ernst Holzer, Peter Hellstern, Manfred Köhler and Frank D. Goebel

Abteilung für Pathologie, Gesellschaft für Strahlen- und Umweltforschung, 8042 Neuherberg/München, Ingolstädter Landstr. 1 [V. E., W. M.]; Medizinische Poliklinik, Ludwig-Maximilians-Universität München [R. H., F. D. G.]; Pathologisches Institut [G. K.], Hautklinik [H. R.], 1. Medizinische Klinik [E. L.] Universität Köln; Zentrum Innere Medizin, Universität Ulm [E. S., H. H.]; 4. Medizinische Abteilung, Städt. Krankenhaus Schwabing [E. H.]; Abteilung für Klinische Haemostaseologie und Transfusionsmedizin, Homburg/Saar [P. H., M. K.]

The prevalence of antibodies to human T-lymphotropic virus III was determined in acquired immunodeficiency syndrome (AIDS) risk groups by an enzyme linked immunosorbent assay and confirmatory tests in four different areas in West Germany. Twenty-four of 28 homosexual AIDS patients (86%), 24 of 33 homosexual patients with lymphadenopathy syndrome or AIDS related complex (73%), and 44 of 113 asymptomatic homosexuals at risk for AIDS (39%) were seropositive. In three groups of hemophiliacs, 8 of 35 in 1983 (23%), 25 of 65 in early 1984 (39%), and 19 of 23 in late 1984 (83%) showed positive results. Two sera from 36 polytransfused patients were also positive, whereas 36 selected blood donors, and 32 healthy laboratory and clinical personnel were all negative. Also no human T-lymphotropic virus III antibodies were detected in sera of 187 prostitutes in the Munich area.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.